Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To visually evaluate the retention of coverage of the Test Product(s) (TP) on the face after exercise compared to the full coverage observed prior to exercise
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Healthy subjects | Experimental | Subject will self-apply the test sunscreen formula to his/her face with the goal of applying 0.65 to 0.85 grams. Subject should sweat profusely. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| BAY987517 | Drug | Sunscreen formula Y65-158 |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change of face coverage post exercise compared to the full coverage observed prior to exercise (in percent) | The expert grader will determine the percentage of coverage achieved by viewing the subject's face through the Skin Scanner | At baseline, and post exercise (30 minutes) |
| Measure | Description | Time Frame |
|---|---|---|
| Report of eye stinging assessed by questionnaire | Subjective assessment of eye stinging (where 0=none to 4=severe) | Up to 30 minutes |
Not provided
Inclusion Criteria:
Subjects may be male or female, of an age of 18-55 years inclusive. Subjects must be capable of understanding and providing written informed consent.
Subjects must sign a written confidentiality agreement including a photography release form.
Subjects must be in good general health as judged by a specified licensed physician, who will indicate their suitability to participate in this study.
Exclusion Criteria:
Subjects must not have received or used an Investigational New Drug within the last 30 days.
Subjects must not have been active participants in another clinical or subjective TP performance study within the last 30 days unless authorized by this Sponsor. Subjects must not have a known physical or medical condition that would preclude vigorous exercise Subjects must not have a five-minute resting pulse rate greater than 80 bpm.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bayer Study Director | Bayer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hill Top Research | St. Petersburg | Florida | 33714 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided